The Memorial Sloan-Kettering Lung Study
The Memorial Sloan-Kettering Lung Study (MEM) was a randomized screening trial designed to test if lung cancer mortality rates could be reduced through the addition of regular cytomorphological screening of sputum to an annual chest x-ray screening regimen. The reported lung cancer mortality rates were similar between the two arms indicating the additional cytological screening did not result in a benefit. The follow-up of participants was of limited duration.
This website is organized into several sections as follows.
- Learn About
This describes the trial, explaining how and what data were collected. The main findings of the trial can be found here.
This page has detailed documentation of the datasets available on this website, including data dictionaries.
- Approved Projects
Search through approved projects that used this trial's data.
Search through published articles on this trial's data.
Begin a new Project
Learn how to access the available datasets.
- Submit a project proposal.
- Brief review by NCI.
- Complete a Data Transfer Agreement.
- Receive access to datasets.
- Contact Us
If you have any questions about the data or access to it, please contact us.